スマート治療機器の世界市場：市場規模・シェア・動向分析 (機器別・流通別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

スマート治療機器市場のサマリー

スマート治療機器の世界市場規模は、2024年に771億2,000万米ドルと推計され、2025年から2030年にかけて12.99%のCAGRで成長し、2030年には1,594億2,000万米ドルに達すると予測されます。この成長は、技術の進歩、慢性疾患の有病率の上昇、個別化医療や在宅医療への需要の高まりに起因します。

この成長は、技術の進歩、慢性疾患の有病率の上昇、個別化された在宅ケアの需要の高まりに起因しています。さらに、インスリンポンプ、スマート吸入器、神経刺激システムなどの携帯型・接続型デバイスの採用が増加しており、特に糖尿病、喘息、COPD、神経疾患などの疾患管理能力が大幅に強化されています。AI、データトラッキング、ワイヤレス接続の統合により、リアルタイムのモニタリング、患者の関与、臨床的意思決定が可能になり、治療成績と患者のアドヒアランスが向上します。

慢性疾患の管理には継続的なケアが必要であるため、スマート治療機器は通院と在宅医療のギャップを埋め、最終的には生活の質の向上と入院率の低下に貢献します。例えば、オムロンヘルスケアは2022年7月、PSA技術を使って90%以上の純酸素を毎分5L供給するポータブル酸素濃縮器を発売しました。在宅介護用に設計され、移動用のキャスター付きでコンパクトかつ耐久性のある設計が特徴です。

さらに、個別化医療の動向は、スマートテクノロジーの採用を加速し続けています。例えば、2024年2月、Tandem Diabetes Care社は、耐久性に優れた世界最小の自動インスリン投与システムTandem Mobiを発売しました。このコンパクトなウェアラブルデバイスは、iOSによる完全なモバイルコントロール、先進的なControl-IQテクノロジー、Dexcom CGMとの互換性を提供し、6歳以上のユーザーにパーソナライズされたインスリン治療を可能にします。

世界保健機関（WHO）によると、2024年現在、心血管疾患、がん、糖尿病、慢性呼吸器疾患などの非感染性疾患（NCDs）は、世界の年間死亡率の74％以上を占めています。これに対しWHOは、NCDの影響を管理・軽減するための費用対効果の高い戦略として、遠隔医療やモバイルヘルス技術を含むデジタルヘルスソリューションへの投資拡大を積極的に推進しています。特に、デジタルヘルスへの介入に患者一人当たり年間わずか0.24米ドルを投資するだけで、今後10年間で200万人以上の命が救われ、700万人近くの急性疾患や入院が予防されると予測されており、これにより世界のヘルスケアシステムへの大きな圧力が緩和されます。

このような世界の要請により、医療テクノロジーのプロバイダーはスマート治療機器ポートフォリオの拡大と多様化を進めています。主な例としては、GN社が2025年2月に発売した、世界最小のAI搭載補聴器とうたわれるリサウンド・ヴィヴィアが挙げられます。1,350万文の実世界の文章で学習させたこの補聴器は、騒がしい環境での会話の明瞭度を大幅に高めると同時に、一日中使用できる最大30時間の長時間バッテリーを提供します。ジーエヌリサウンドはまた、Bluetooth LEオーディオとAuracast放送機能を備えた価値主導型の製品ラインであるリサウンド・サヴィを発表しました。

COVID-19の大流行により、ポータブル酸素濃縮器や人工呼吸器などのスマート治療機器の需要が大幅に高まり、呼吸器合併症の管理に不可欠となりました。スマート吸入器、コネクテッド吸入器、COPD管理ツールは、呼吸器疾患に対する意識の高まりにより脚光を浴びた。一方、インスリンポンプ、ウェアラブル注射器、埋め込み型ドラッグデリバリーは、慢性疾患患者の通院を減らすのに役立ちました。パンデミックはまた、遠隔医療統合による神経刺激や聴覚機器の採用を後押ししました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変動要因・傾向・範囲

• 市場連関の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
  • 業界機会分析
  • 業界の課題分析
  • ケーススタディ
• ビジネス環境分析
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
• COVID-19の影響分析

第4章 スマート治療機器市場：治療機器の種類別の推定・動向分析

• セグメントダッシュボード：治療機器別
• 市場シェアと変動分析：治療機器別（2024年・2030年）
• 市場規模の予測と動向分析：治療機器の種類別（2018～2030年）
  • ポータブル酸素濃縮器・人工呼吸器
  • インスリンポンプ
  • 補聴器
  • 神経刺激装置
  • スマート吸入器
  • スマート薬剤送達システム

第5章 スマート治療機器市場：流通チャネル別の推定・動向分析

• セグメントダッシュボード：流通別
• 市場シェアと変動分析：流通別（2024年・2030年）
• 市場規模の予測と動向分析：流通チャネル別（2018～2030年）
• 薬局
  • 薬局市場（2018年～2030年）
• オンラインチャンネル
  • オンラインチャネル市場（2018年～2030年）
• 消費者直販（DTC）
  • 消費者直販（DTC）市場（2018年～2030年）
• その他（ハイパーマーケット、専門小売店）
  • その他（ハイパーマーケット、専門小売店）市場（2018年～2030年）

第6章 スマート治療機器市場：最終用途別の推定・動向分析

• セグメントダッシュボード：最終用途別
• 市場シェアと変動分析：最終用途別（2024年・2030年）
• 市場規模の予測と動向分析：最終用途別（2018～2030年）
• 病院
  • 病院市場（2018年～2030年）
• クリニック
  • クリニック市場（2018年～2030年）
• 在宅医療
  • 在宅医療市場（2018年～2030年）
• その他（スポーツ、フィットネスセンター、介護付き住宅）
  • その他（スポーツ、フィットネスセンター、介護付き住宅）市場（2018年～2030年）

第7章 スマート治療機器市場：地域別の推定・動向分析

• 市場ダッシュボード：地域別
• 地域別市場：主なポイント
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Inogen, Inc.
  • Presspart Verwaltungs GmbH.
  • Cognita Labs
  • adherium
  • Medtronic
  • Hoffmann-La Roche AG
  • Insulet Corporation
  • Audicus
  • Eargo, Inc.
  • Nidek Medical Products, Inc.
  • Koninklijke Philips NV
  • Drive Devilbiss International
  • Tandem Diabetes Care, Inc.
  • Ypsomed
  • GN Hearing
  • Cochlear Ltd.
  • Sonova.
  • Boston Scientific Corporation
  • Abbott.
  • Nevro Corp.

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 North America smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
• Table 4 North America smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 5 North America smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 6 North America smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 8 U.S. smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 9 U.S. smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 10 Canada smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 11 Canada smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 12 Canada smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 13 Mexico smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 14 Mexico smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 15 Mexico smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 16 Europe smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 17 Europe smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 18 Europe smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 19 UK smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 20 UK smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 21 UK smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 22 Germany smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 23 Germany smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 24 Germany smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 25 France smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 26 France smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 27 France smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 28 Italy smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 29 Italy smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 30 Italy smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 31 Spain smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 32 Spain smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 33 Spain smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 34 Norway smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 35 Norway smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 36 Norway smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 37 Sweden smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 38 Sweden smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 39 Sweden smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 40 Denmark smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 41 Denmark smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 42 Denmark smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 47 Japan smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 48 Japan smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 49 Japan smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 50 China smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 51 China smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 52 China smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 53 India smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 54 India smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55 India smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 56 Australia smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 57 Australia smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 58 Australia smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 59 South Korea smart therapeutic devices market, by devices types, 2018 - 2030 (USD Million)
• Table 60 South Korea smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 61 South Korea smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 62 Thailand smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 63 Thailand smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 64 Thailand smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 65 Latin America smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
• Table 66 Latin America smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 67 Latin America smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 68 Latin America smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 69 Brazil smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 70 Brazil smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 71 Brazil smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 72 Argentina smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 73 Argentina smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 74 Argentina smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 75 Middle East & Africa smart therapeutic devices market, by country, 2018 - 2030 (USD Million)
• Table 76 Middle East & Africa smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 77 Middle East & Africa smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 78 Middle East & Africa smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 79 South Africa smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 80 South Africa smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 81 South Africa smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 85 UAE smart therapeutic devices market, devices types , 2018 - 2030 (USD Million)
• Table 86 UAE smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 87 UAE smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)
• Table 88 Kuwait smart therapeutic devices market, devices types, 2018 - 2030 (USD Million)
• Table 89 Kuwait smart therapeutic devices market, by distribution channel, 2018 - 2030 (USD Million)
• Table 90 Kuwait smart therapeutic devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Smart therapeutics devices market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market formulation & validation
• Fig. 6 Market research approaches
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD modelling for market share assessment
• Fig. 9 Commodity flow analysis
• Fig. 10 Market snapshot
• Fig. 11 Market segmentation (USD Million
• Fig. 12 Competitive landscape
• Fig. 13 Parent market outlook (In USD Billion)
• Fig. 14 Related/ancillary market outlook (In USD Billion)
• Fig. 15 Smart therapeutics devices market dynamics
• Fig. 16 Smart therapeutics devices market: Porter's five forces analysis
• Fig. 17 Smart therapeutics devices market: PESTLE analysis
• Fig. 18 Smart therapeutics devices market: Devices Type segment dashboard
• Fig. 19 Smart therapeutics devices market: Devices Type market share analysis, 2024 & 2030
• Fig. 20 Portable Oxygen Concentrators & Ventilators market, 2018 - 2030 (USD Million)
• Fig. 21 Insulin Pumps market, 2018 - 2030 (USD Million)
• Fig. 22 Hearing Aids market, 2018 - 2030 (USD Million)
• Fig. 23 Neurostimulation Devices market, 2018 - 2030 (USD Million)
• Fig. 24 Spinal Cord Stimulation market, 2018 - 2030 (USD Million)
• Fig. 25 Deep Brain Stimulation market, 2018 - 2030 (USD Million)
• Fig. 26 Transcranial Magnetic Stimulation market, 2018 - 2030 (USD Million)
• Fig. 27 Smart Inhalers market, 2018 - 2030 (USD Million)
• Fig. 28 Asthma & COPD Management market, 2018 - 2030 (USD Million)
• Fig. 29 Connected Inhalers with Data Tracking market, 2018 - 2030 (USD Million)
• Fig. 30 Smart Drug Delivery Systems market, 2018 - 2030 (USD Million)
• Fig. 31 Wearable Injectors market, 2018 - 2030 (USD Million)
• Fig. 32 Drug Delivery Devices market, 2018 - 2030 (USD Million)
• Fig. 33 Smart therapeutic devices market: Distribution market share analysis, 2024 & 2030
• Fig. 34 Pharmacies market, 2018 - 2030 (USD Million)
• Fig. 35 Online Channel market, 2018 - 2030 (USD Million
• Fig. 36 Direct-to-Consumer (DTC) market, 2018 - 2030 (USD Million
• Fig. 37 Others (Hypermarkets, Specialty Retailers) market, 2018 - 2030 (USD Million
• Fig. 38 Smart therapeutic devices market: End use market share analysis, 2024 & 2030
• Fig. 39 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 40 Clinics market, 2018 - 2030 (USD Million)
• Fig. 41 Home Care market, 2018 - 2030 (USD Million)
• Fig. 42 Others (Sports, Fitness Centers, Assisted Living) market, 2018 - 2030 (USD Million)
• Fig. 43 Smart therapeutic devices market revenue, by region
• Fig. 44 Regional marketplace: Key takeaways
• Fig. 45 North America smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 US smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Canada smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Mexico smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 52 Europe smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 UK smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Germany smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 France smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Italy smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Spain smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Norway smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Sweden smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Denmark smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 69 Asia Pacific smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Japan smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 China smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 India smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 Australia smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 South Korea smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Thailand smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 82 Latin America smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 Brazil smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Argentina smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 87 MEA smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 South Africa smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 Saudi Arabia smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 UAE smart therapeutic devices market, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 Kuwait healthcare information system market, 2018 - 2030 (USD Million)
• Fig. 96 Company categorization
• Fig. 97 Company market position analysis
• Fig. 98 Strategic framework

Smart Therapeutic Devices Market Summary

The global smart therapeutic devices market size was estimated at USD 77.12 billion in 2024 and is projected to reach USD 159.42 billion by 2030, growing at a CAGR of 12.99% from 2025 to 2030. This growth is attributed to technological advancements, rising prevalence of chronic diseases, and the growing demand for personalized and home-based care.

This growth is attributed to technological advancements, rising prevalence of chronic diseases, and the growing demand for personalized and home-based care. Moreover, increasing adoption of portable and connected devices-such as insulin pumps, smart inhalers, and neurostimulation systems-has significantly enhanced disease management capabilities, particularly for conditions like diabetes, asthma, COPD, and neurological disorders. The integration of AI, data tracking, and wireless connectivity enables real-time monitoring, patient engagement, and clinical decision-making, thereby improving treatment outcomes and patient adherence.

With chronic disease management requiring continuous care, smart therapeutic devices bridge the gap between hospital visits and home-based healthcare, ultimately contributing to improved quality of life and reduced hospitalization rates. For instance, in July 2022, OMRON Healthcare launched a portable oxygen concentrator delivering 5L/min of >90% pure oxygen using PSA technology. Designed for home care, it features a compact, durable design with caster wheels for mobility.

Moreover, the trend toward personalized medicine continues to accelerate the adoption of smart technologies. For instance, in February 2024, Tandem Diabetes Care launched Tandem Mobi, the world's smallest durable automated insulin delivery system. This compact, wearable device offers full iOS mobile control, advanced Control-IQ technology, and compatibility with Dexcom CGMs, enabling personalized insulin therapy for users aged six and up.

According to the World Health Organization (WHO), as of 2024, noncommunicable diseases (NCDs) such as cardiovascular diseases, cancer, diabetes, and chronic respiratory conditions account for over 74% of global mortality annually. In response, the WHO is actively promoting greater investment in digital health solutions-including telemedicine and mobile health technologies-as a cost-effective strategy to manage and mitigate the impact of NCDs. Notably, an investment of merely USD 0.24 per patient per year in digital health interventions is projected to save over 2 million lives and prevent nearly 7 million acute events and hospitalizations over the next decade, thereby alleviating significant pressure on global healthcare systems.

These global imperatives are driving healthcare technology providers to expand and diversify their smart therapeutic device portfolios. A key example is GN's February 2025 launch of ReSound Vivia, touted as the world's smallest AI-powered hearing aid. Trained on 13.5 million real-world sentences, the device significantly enhances speech clarity in noisy environments while offering extended battery life of up to 30 hours for all-day use. GN also introduced ReSound Savi, a value-driven product line featuring Bluetooth LE Audio and Auracast broadcast capabilities-further democratizing access to advanced hearing solutions and aligning with global digital health priorities.

The COVID-19 pandemic significantly increased the demand for smart therapeutic devices like portable oxygen concentrators and ventilators became critical for managing respiratory complications. Smart inhalers, connected inhalers, and COPD management tools gained prominence due to the rise in respiratory illness awareness. On the other hand, insulin pumps, wearable injectors, and implantable drug delivery devices helped reduce hospital visits for chronic disease patients. The pandemic also pushed the adoption of neurostimulation and hearing devices through telehealth integration.

Global Smart Therapeutic Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global smart therapeutic devices market report based on devices, distribution, end use and regions.

• Devices Type Outlook (Revenue, USD Million, 2018 - 2030)
• Portable Oxygen Concentrators & Ventilators
• Insulin Pumps
• Hearing Aids
• Neurostimulation Devices
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Transcranial Magnetic Stimulation
• Smart Inhalers
  • Asthma & COPD Management
  • Connected Inhalers with Data Tracking
• Smart Drug Delivery Systems
  • Wearable Injectors
  • Implantable Drug Delivery Devices
• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Pharmacies
• Online Channel
• Direct-to-Consumer (DTC)
• Others (Hypermarkets, Specialty Retailers)
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Clinics
• Home Care
• Others (Sports, Fitness Centers, Assisted Living)
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Therapeutic Devices
  • 1.2.2. Device/Product
  • 1.2.3. Technology/Software
  • 1.2.4. Distribution
  • 1.2.5. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increase in personalized treatment plans
    • 3.2.1.2. Technological Advancements
    • 3.2.1.3. Rising Prevalence of Chronic Diseases
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Case Studies
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
• 3.4. COVID 19 Impact Analysis

Chapter 4. Smart Therapeutics Devices Market: Therapeutic Devices Type Estimates & Trend Analysis

• 4.1. Therapeutic Devices Segment Dashboard
• 4.2. Therapeutic Devices Market Share Movement Analysis, 2024 & 2030
• 4.3. Market Size & Forecasts and Trend Analysis, by Devices Type, 2018 to 2030 (USD Million)
  • 4.3.1. Portable Oxygen Concentrators & Ventilators
    • 4.3.1.1. Portable Oxygen Concentrators & Ventilators market, 2018 - 2030 (USD Million)
  • 4.3.2. Insulin Pumps
    • 4.3.2.1. Insulin Pumps market, 2018 - 2030 (USD Million)
  • 4.3.3. Hearing Aids
    • 4.3.3.1. Hearing Aids market, 2018 - 2030 (USD Million)
  • 4.3.4. Neurostimulation Devices
    • 4.3.4.1. Neurostimulation Devices market, 2018 - 2030 (USD Million)
    • 4.3.4.2. Spinal Cord Stimulation
      • 4.3.4.2.1. Spinal Cord Stimulation market, 2018 - 2030 (USD Million)
    • 4.3.4.3. Deep Brain Stimulation
      • 4.3.4.3.1. Deep Brain Stimulation market, 2018 - 2030 (USD Million)
    • 4.3.4.4. Transcranial Magnetic Stimulation
      • 4.3.4.4.1. Transcranial Magnetic Stimulation market, 2018 - 2030 (USD Million)
  • 4.3.5. Smart Inhalers
    • 4.3.5.1. Smart Inhalers market, 2018 - 2030 (USD Million)
    • 4.3.5.2. Asthma & COPD Management
      • 4.3.5.2.1. Asthma & COPD Management market, 2018 - 2030 (USD Million)
    • 4.3.5.3. Connected Inhalers with Data Tracking
      • 4.3.5.3.1. Connected Inhalers with Data Tracking market, 2018 - 2030 (USD Million)
  • 4.3.6. Smart Drug Delivery Systems
    • 4.3.6.1. Smart Drug Delivery Systems market, 2018 - 2030 (USD Million)
    • 4.3.6.2. Wearable Injectors
      • 4.3.6.2.1. Wearable Injectors market, 2018 - 2030 (USD Million)
    • 4.3.6.3. Drug Delivery Devices
      • 4.3.6.3.1. Drug Delivery Devices market, 2018 - 2030 (USD Million)

Chapter 5. Smart Therapeutics Devices Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Distribution Segment Dashboard
• 5.2. Distribution Market Share Movement Analysis, 2024 & 2030
• 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 5.4. Pharmacies
  • 5.4.1. Pharmacies market, 2018 - 2030 (USD Million)
• 5.5. Online Channel
  • 5.5.1. Online Channel market, 2018 - 2030 (USD Million)
• 5.6. Direct-to-Consumer (DTC)
  • 5.6.1. Direct-to-Consumer (DTC) market, 2018 - 2030 (USD Million)
• 5.7. Others (Hypermarkets, Specialty Retailers)
  • 5.7.1. Others (Hypermarkets, Specialty Retailers) market, 2018 - 2030 (USD Million)

Chapter 6. Smart Therapeutics Devices Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. End Use Market Share Movement Analysis, 2024 & 2030
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market, 2018 - 2030 (USD Million)
• 6.5. Clinics
  • 6.5.1. Clinics market, 2018 - 2030 (USD Million)
• 6.6. Home Care
  • 6.6.1. Home Care market, 2018 - 2030 (USD Million)
• 6.7. Others (Sports, Fitness Centers, Assisted Living)
  • 6.7.1. Others (Sports, Fitness Centers, Assisted Living) market, 2018 - 2030 (USD Million)

Chapter 7. Smart Therapeutics Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market: Key Takeaways
• 7.3. North America
  • 7.3.1. North America smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamic
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive insights
    • 7.3.2.4. U.S. smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamic
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive insights
    • 7.3.3.4. Canada smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamic
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive insights
    • 7.3.4.4. Mexico smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. Germany smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. UK smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. France smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamic
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive insights
    • 7.4.5.4. Italy smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamic
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive insights
    • 7.4.6.4. Spain smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamic
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive insights
    • 7.4.7.4. Denmark smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamic
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive insights
    • 7.4.8.4. Sweden smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamic
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive insights
    • 7.4.9.4. Norway smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. Japan smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. China smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. India smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. South Korea smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Australia smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Thailand smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America smart therapeutics devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Brazil smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. Argentina smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. South Africa smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Saudi smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamic
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive insights
    • 7.7.4.4. UAE smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamic
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive insights
    • 7.7.5.4. Kuwait smart therapeutics devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Inogen, Inc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Presspart Verwaltungs GmbH.
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Cognita Labs
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. adherium
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. Medtronic
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. Hoffmann-La Roche AG
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. Insulet Corporation
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Audicus
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Eargo, Inc.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Products & Services benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Nidek Medical Products, Inc.
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Koninklijke Philips N.V.
    • 8.5.11.1. Overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Drive Devilbiss International
    • 8.5.12.1. Overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Tandem Diabetes Care, Inc.
    • 8.5.13.1. Overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Ypsomed
    • 8.5.14.1. Overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. GN Hearing
    • 8.5.15.1. Overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. Cochlear Ltd.
    • 8.5.16.1. Overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product benchmarking
    • 8.5.16.4. Strategic initiatives
  • 8.5.17. Sonova.
    • 8.5.17.1. Overview
    • 8.5.17.2. Financial performance
    • 8.5.17.3. Product benchmarking
    • 8.5.17.4. Strategic initiatives
  • 8.5.18. Boston Scientific Corporation
    • 8.5.18.1. Overview
    • 8.5.18.2. Financial performance
    • 8.5.18.3. Product benchmarking
    • 8.5.18.4. Strategic initiatives
  • 8.5.19. Abbott.
    • 8.5.19.1. Overview
    • 8.5.19.2. Financial performance
    • 8.5.19.3. Product benchmarking
    • 8.5.19.4. Strategic initiatives
  • 8.5.20. Nevro Corp.
    • 8.5.20.1. Overview
    • 8.5.20.2. Financial performance
    • 8.5.20.3. Product benchmarking
    • 8.5.20.4. Strategic initiatives